Clinical trial
Treatment Resistant Bipolar Depression
NCT00272025 · Queen's University, Other · Terminated
Key facts
| NCT number | NCT00272025 |
|---|---|
| Title | Treatment Resistant Bipolar Depression |
| Official title | Six Week Double Blind, Randomized Trial of Escitalopram Add On for Treatment Resistant Bipolar Depression |
| Lead sponsor | Queen's University, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Bipolar Depression |
| Intervention type | Drug |
| Interventions | Escitalopram, placebo |
| Enrollment | 1 |
| Start date | Oct 1, 2006 |
| Primary completion | Jan 1, 2010 |
| Completion | Jan 1, 2010 |
| First posted | Jan 4, 2006 |
| Last update posted | Dec 16, 2015 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: